BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹26 Cr | ₹-0.16 Cr | ₹3.65 Cr | ₹18 Cr | - |
What is the latest Cash Flow from Financing Activities ratio of BALAXI PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹26 Cr |
Mar2022 | ₹-0.16 Cr |
Mar2021 | ₹3.65 Cr |
Mar2020 | ₹18 Cr |
Mar2019 | - |
How is Cash Flow from Financing Activities of BALAXI PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹26 Cr | Positive | |
Mar2022 | ₹-0.16 Cr | Negative | |
Mar2021 | ₹3.65 Cr | -79.85 | |
Mar2020 | ₹18 Cr | 0 | |
Mar2019 | - | - |
Compare Cash Flow from Financing Activities of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹643.5 Cr | 2.2% | 15% | 7.1% | Stock Analytics | |
ADANI ENTERPRISES | ₹351,109.0 Cr | 0.5% | -0.8% | 72.9% | Stock Analytics | |
REDINGTON | ₹17,402.3 Cr | 2.2% | 8.4% | 31.6% | Stock Analytics | |
HONASA CONSUMER | ₹13,911.7 Cr | 6.1% | 16% | NA | Stock Analytics | |
MMTC | ₹11,448.0 Cr | 5.3% | 14.8% | 155.7% | Stock Analytics | |
MSTC | ₹6,407.1 Cr | 4.7% | 6.3% | 242.8% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | 2.2% |
15% |
7.1% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses